You are using an unsupported browser. Please use the latest version of Chrome, Firefox, Safari or Edge.

Cancer Center

We are committed to transforming cancer care for generations to come.

Massachusetts General Hospital has a long history of innovation and impact in cancer research and care. We are building on that legacy today by hosting:

open clinical trials each year
0 +
treatment programs for adults and children
laboratories at the Krantz Family Center for Cancer Research

Latasha was diagnosed with triple negative breast cancer in 2018, and subsequently enrolled in a clinical trial developed at the Mass General Cancer Center. Latasha shares her personal story of how she came to enroll in the trial, what the experience was like for her, and what the results mean for her health and for others like her.

An Ideal Home

Our team has the compassion, talent and resources — and an ideal home in the heart of Boston‘s unparalleled health care and research ecosystem — to continue breaking new ground. We’re leaders in:

  • Clinical Care: The Mass General Cancer Center brings together specialists from across the hospital to offer patients the best chance for the best outcome — before, during and following treatment. The Mass General Cancer Center cares for 50,000 unique patients each year, including 20,000 new patients.
  • Cancer Research: The Krantz Family Center for Cancer Research is the Mass General Cancer Center’s major hub for basic and translational research, where investigators lead groundbreaking efforts aimed at understanding the fundamental biology of cancer and applying that knowledge toward its eradication. Our researchers take discoveries directly from the lab bench to the clinic to inform the development of novel treatments — including chimeric antigen receptor T (CAR-T) cell therapies, high-level immunotherapies and neoadjuvant therapies.
  • First-in-Human Clinical Trials: At the Henri and Belinda Termeer Center for Targeted Therapies, patients enroll in first-in-human, biomarker-driven clinical trials for all types of novel cancer therapies — including immunotherapies, targeted therapies, antibody drug conjugates and cellular therapies.
  • Supportive Care: Mass General Cancer Center patients have access to 26 supportive care programs — including an award-winning program for patients who are parents of young children, advanced psychosocial support services, integrative therapies such as massage and acupuncture, and programs that infuse our spaces with art, music and healing.
Cancer Center Research

Imagine a future where ...

  • Primary care providers actively screen healthy individuals for cancers during routine wellness visits.
  • Genetic and environmental risk factors are calculated to create individualized screening algorithms, and periodic blood tests are performed to detect subtle signals of cancers anywhere within the body.
  • Sophisticated imaging tools identify the earliest invasive tumors, which can be removed surgically or treated with radiation.
  • Targeted therapies and immunotherapies destroy the small number of cancer cells that may have escaped from the primary tumor before they spread.
  • Advanced telemedicine operations and expanded access to Mass General’s satellite locations make high-quality cancer care available to patients closer to home.

Thanks to our unequaled expertise, which extends from primary care to specialized services, Mass General is uniquely positioned to bring this future to life.

Jason and Keely Krantz
Featured Story

Fueling the Engine of Cancer Discovery

A transformative gift from philanthropists Jason and Keely Krantz is about to revolutionize cancer research at Mass General Cancer Center.

Read More

We’re investing in …

Doctor talking with patient
Researcher working
Joe Betancourt speaking